https://pharminent.com/82051-2/ 2026-06-17T20:27:14Z Pharminent en 2026-06-17T20:27:11Z Blog https://pharminent.com/82048-2/ 2026-06-17T19:47:04Z Pharminent en 2026-06-17T19:47:01Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-june-17-2026/ 2026-06-17T18:49:00Z Pharminent en Manufacturing Intelligence • Weekly Digest • June 17, 2026 2026-06-17T18:48:58Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-17-2026/ 2026-06-17T16:08:09Z Pharminent en Strategic News Watch • June 17, 2026 2026-06-17T16:07:54Z Blog https://pharminent.com/jazz-orchestrates-a-4bn-cancer-alliance-with-abcellera/ 2026-06-17T20:16:30Z Pharminent en Jazz orchestrates a $4bn cancer alliance with AbCellera 2026-06-17T12:03:37Z Blog https://pharminent.com/edgewise-slides-as-cardiomyopathy-challenger-to-bms-cytokinetics-falls-short/ 2026-06-17T15:10:56Z Pharminent en Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short 2026-06-17T11:58:04Z Blog https://pharminent.com/merck-adds-to-biopharmas-ai-agenda-with-up-to-510m-protillion-pact/ 2026-06-17T15:06:19Z Pharminent en Merck adds to biopharma's AI agenda with up to $510M+ Protillion pact 2026-06-17T11:20:10Z Blog https://pharminent.com/moderna-builds-commercial-muscle-as-new-launches-loom/ 2026-06-17T15:09:08Z Pharminent en Moderna builds commercial muscle as new launches loom 2026-06-17T09:57:56Z Blog https://pharminent.com/altaris-to-acquire-simulations-plus-in-375m-all-cash-deal/ 2026-06-17T15:10:29Z Pharminent en Altaris to acquire Simulations Plus in $375m all-cash deal 2026-06-17T09:51:25Z Blog https://pharminent.com/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates/ 2026-06-17T20:15:57Z Pharminent en EHA26: BMS touts positive multiple myeloma data for two pipeline candidates 2026-06-17T09:32:42Z Blog https://pharminent.com/81994-2/ 2026-06-17T19:10:56Z Pharminent en 2026-06-16T20:41:14Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-june-16-2026/ 2026-06-16T20:29:19Z Pharminent en Oncology Intelligence Digest • June 16, 2026 2026-06-16T20:29:16Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-june-12-2026/ 2026-06-16T20:16:22Z Pharminent en Oncology Intelligence Digest • June 12, 2026 2026-06-16T20:16:20Z Blog https://pharminent.com/81986-2/ 2026-06-16T18:02:12Z Pharminent en 2026-06-16T18:02:09Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-16-2026/ 2026-06-16T16:12:30Z Pharminent en Strategic News Watch • June 16, 2026 2026-06-16T16:12:27Z Blog https://pharminent.com/fda-moderna-appear-aligned-on-mrna-flu-shot-heading-into-adcomm/ 2026-06-16T15:24:53Z Pharminent en FDA, Moderna appear aligned on mRNA flu shot heading into adcomm 2026-06-16T15:24:53Z Blog https://pharminent.com/german-said-to-be-backtracking-on-pharma-rebate-changes/ 2026-06-16T16:23:56Z Pharminent en German said to be backtracking on pharma rebate changes 2026-06-16T12:44:11Z Blog https://pharminent.com/fda-and-mhra-forge-new-regulatory-collaboration-initiative/ 2026-06-16T15:43:20Z Pharminent en FDA and MHRA forge new regulatory collaboration initiative 2026-06-16T10:17:33Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-june-15-2026/ 2026-06-15T21:45:54Z Pharminent en Rare Disease & Gene Therapy Digest • June 15, 2026 2026-06-15T21:45:51Z Blog https://pharminent.com/81927-2/ 2026-06-15T21:43:01Z Pharminent en 2026-06-15T21:42:53Z Blog https://pharminent.com/81923-2/ 2026-06-15T18:39:12Z Pharminent en 2026-06-15T18:39:08Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-15-2026/ 2026-06-15T16:53:19Z Pharminent en Strategic News Watch • June 15, 2026 2026-06-15T16:53:17Z Blog https://pharminent.com/eisai-claims-uk-grant-to-expand-manufacturing-site/ 2026-06-15T14:15:47Z Pharminent en Eisai claims UK grant to expand manufacturing site 2026-06-15T12:19:37Z Blog https://pharminent.com/key-pipeline-drug-for-lundbeck-delivers-in-cushing-syndrome/ 2026-06-15T14:46:08Z Pharminent en Key pipeline drug for Lundbeck delivers in Cushing syndrome 2026-06-15T11:37:08Z Blog https://pharminent.com/rhythms-obesity-drug-scores-better-than-expected-weight-loss-in-rare-genetic-disease/ 2026-06-15T14:15:23Z Pharminent en Rhythm's obesity drug scores 'better than expected' weight loss in rare genetic disease 2026-06-15T11:24:33Z Blog https://pharminent.com/lilly-sees-quick-return-on-2-3b-ajax-buy-as-blood-cancer-drug-shows-early-efficacy/ 2026-06-15T15:31:15Z Pharminent en Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy 2026-06-15T10:51:02Z Blog https://pharminent.com/data-could-move-jjs-talvey-earlier-in-myeloma-therapy/ 2026-06-15T14:46:51Z Pharminent en Data could move J&J's Talvey earlier in myeloma therapy 2026-06-15T10:12:18Z Blog https://pharminent.com/fda-clears-msds-keytruda-combo-plus-welireg-for-ccrcc-treatment/ 2026-06-15T14:15:00Z Pharminent en FDA clears MSD's Keytruda combo plus Welireg for ccRCC treatment 2026-06-15T08:55:49Z Blog